VIGADEXA Gel Compared to VIGADEXA Solution Following Cataract Surgery

NCT01515826 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Management decision

Conditions

Cataracts

Interventions

DRUG: Moxifloxacin 0.5%/Dexamethasone Phosphate 0.075% Ophthalmic Gel (VIGADEXA Gel)
DRUG: Moxifloxacin 0.5%/Dexamethasone Phosphate 0.1% Ophthalmic Solution (VIGADEXA Solution)

Sponsor

Alcon Research